Home Stock

Stock Research: Bangkok Chain Hospital

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Bangkok Chain Hospital

SET:BCH TH0808010Y07
52
  • Value
    42
  • Growth
    50
  • Safety
    Safety
    78
  • Combined
    67
  • Sentiment
    49
  • 360° View
    360° View
    52
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Bangkok Chain Hospital Public Company Limited provides healthcare services through private hospitals and nursing. Its main businesses include medical treatment, selling healthy drinks, medical analysis and research, and asset management relevant to hospitals. It operates in the Bangkok vicinity, Chiang Rai, Saraburi, Nonthaburi, Pathumthani, Ayudhaya, Chachoengsao, Prachinburi, Sa Kaeo Province, and Lao People’s Democratic Republic. In the last fiscal year, the company had 7054 employees, a market cap of $1019 million, profits of $95 million, and revenue of $344 million.

more

ANALYSIS: With an Obermatt 360° View of 52 (better than 52% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bangkok Chain Hospital are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Bangkok Chain Hospital. The consolidated Growth Rank has a good rank of 50, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 50% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 78 which means that the company has a financing structure that is safer than 78% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 42 which means that the share price of Bangkok Chain Hospital is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 58% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 49, which means that professional investors are more pessimistic about the stock than for 51% of alternative investment opportunities. ...read more

more
Strongest Rank Revenue Growth
Weakest Rank Safety
Country Thailand
Industry Health Care Facilities
Size Medium
Website bangkokchainhospital.com
Index
SET
Bangkok Chain Hospital stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 11-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
42 59 32 45
Growth
50 3 15 79
Safety
Safety
78 69 59 33
Sentiment
49 67 44 90
360° View
360° View
52 48 19 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
34 77 58 44
Opinions Change
50 22 50 60
Pro Holdings
n/a 44 63 94
Market Pulse
60 100 26 79
Sentiment
49 67 44 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
42 59 32 45
Growth
50 3 15 79
Safety Safety
78 69 59 33
Combined
67 35 17 52
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
37 47 30 35
Price vs. Earnings (P/E)
27 45 34 40
Price vs. Book (P/B)
38 51 38 29
Dividend Yield
78 76 64 70
Value
42 59 32 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
15 32 31 4
Profit Growth
51 10 11 94
Capital Growth
76 42 26 42
Stock Returns
60 13 51 91
Growth
50 3 15 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
67 64 46 12
Refinancing
58 21 23 53
Liquidity
74 70 79 60
Safety Safety
78 69 59 33

Similar Stocks

Discover high‑ranked alternatives to Bangkok Chain Hospital and broaden your portfolio horizons.

Aurobindo Pharma

NSI:AUROPHARMA
Country: India
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Regional Container Lines

SET:RCL
Country: Thailand
Industry: Marine
Size: Medium
Full Stock Analysis

Sri Trang Gloves (Thailand)

SET:STGT
Country: Thailand
Industry: Health Care Supplies
Size: Medium
Full Stock Analysis

Thai Oil

SET:TOP
Country: Thailand
Industry: Oil & Gas Refining
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews